Verge Genomics - Tech Innovator Profile
Verge Genomics is an AI-driven biopharmaceutical drug discovery company which applies patient genomes, epigenomics, and gene expression for identifying novel effective drugs, stratify patient subpopulations, and therapeutic gene targets for accelerating clinical success.
The report provides information and insights into Verge Genomicss, including -
- Overview of the company and its product offering
- Detailed insight into its business model, company type and headquarter
- Information on funding
- Biography of top management
Reasons to Buy
- Gain insights into Verges business operations.
- Gain insights into funding and partnerships
- Gain understanding about its technology focus.
Operator migration strategies for the converged 5G core market research report available in single user pdf license with Aarkstore Enterprise at USD 1499View Report
Telecom Convergence (2021) - Thematic ResearchIn an age of increasingly connected living, working, and playing, telecom operators are re-positioning themselves from conduits of commoditizing connectivity to all-round, end-to-end, and value-addedView Report
Genomics - Thematic ResearchThis report focuses on genomics products in the direct-to-consumer sector. Direct-to-consumer genetic testing is a rapidly expanding market that is generating substantial amounts of revenue and publicView Report
WuXi NextCODE Genomics (WuXi NextCODE), formerly NextCODE Health is a subsidiary of WuXi PharmaTech (Cayman), Inc., medical device company that offers clinical diagnostics services. The company delivers genomics platform toView Report
Fill The Form For Sample Request